Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hurdles to breakthrough in CAR T cell therapy of solid tumors.
Marofi F, Achmad H, Bokov D, Abdelbasset WK, Alsadoon Z, Chupradit S, Suksatan W, Shariatzadeh S, Hasanpoor Z, Yazdanifar M, Shomali N, Khiavi FM. Marofi F, et al. Among authors: yazdanifar m. Stem Cell Res Ther. 2022 Apr 1;13(1):140. doi: 10.1186/s13287-022-02819-x. Stem Cell Res Ther. 2022. PMID: 35365241 Free PMC article. Review.
A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions.
Marofi F, Rahman HS, Achmad MH, Sergeevna KN, Suksatan W, Abdelbasset WK, Mikhailova MV, Shomali N, Yazdanifar M, Hassanzadeh A, Ahmadi M, Motavalli R, Pathak Y, Izadi S, Jarahian M. Marofi F, et al. Among authors: yazdanifar m. Front Immunol. 2021 Jun 23;12:681984. doi: 10.3389/fimmu.2021.681984. eCollection 2021. Front Immunol. 2021. PMID: 34248965 Free PMC article. Retracted. Review.
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies.
Razeghian E, Nasution MKM, Rahman HS, Gardanova ZR, Abdelbasset WK, Aravindhan S, Bokov DO, Suksatan W, Nakhaei P, Shariatzadeh S, Marofi F, Yazdanifar M, Shamlou S, Motavalli R, Khiavi FM. Razeghian E, et al. Among authors: yazdanifar m. Stem Cell Res Ther. 2021 Jul 28;12(1):428. doi: 10.1186/s13287-021-02510-7. Stem Cell Res Ther. 2021. PMID: 34321099 Free PMC article. Review.
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies.
Marofi F, Saleh MM, Rahman HS, Suksatan W, Al-Gazally ME, Abdelbasset WK, Thangavelu L, Yumashev AV, Hassanzadeh A, Yazdanifar M, Motavalli R, Pathak Y, Naimi A, Baradaran B, Nikoo M, Khiavi FM. Marofi F, et al. Among authors: yazdanifar m. Stem Cell Res Ther. 2021 Jul 2;12(1):374. doi: 10.1186/s13287-021-02462-y. Stem Cell Res Ther. 2021. PMID: 34215336 Free PMC article. Review.
Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy.
Hassanzadeh A, Altajer AH, Rahman HS, Saleh MM, Bokov DO, Abdelbasset WK, Marofi F, Zamani M, Yaghoubi Y, Yazdanifar M, Pathak Y, Chartrand MS, Jarahian M. Hassanzadeh A, et al. Among authors: yazdanifar m. Front Cell Dev Biol. 2021 Jul 12;9:686453. doi: 10.3389/fcell.2021.686453. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34322483 Free PMC article. Retracted. Review.
CAR-NK cell in cancer immunotherapy; A promising frontier.
Marofi F, Abdul-Rasheed OF, Rahman HS, Budi HS, Jalil AT, Yumashev AV, Hassanzadeh A, Yazdanifar M, Motavalli R, Chartrand MS, Ahmadi M, Cid-Arreguid A, Jarahian M. Marofi F, et al. Among authors: yazdanifar m. Cancer Sci. 2021 Sep;112(9):3427-3436. doi: 10.1111/cas.14993. Epub 2021 Jul 7. Cancer Sci. 2021. PMID: 34050690 Free PMC article. Review.
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy.
Marofi F, Al-Awad AS, Sulaiman Rahman H, Markov A, Abdelbasset WK, Ivanovna Enina Y, Mahmoodi M, Hassanzadeh A, Yazdanifar M, Stanley Chartrand M, Jarahian M. Marofi F, et al. Among authors: yazdanifar m. Front Oncol. 2021 Jun 10;11:673276. doi: 10.3389/fonc.2021.673276. eCollection 2021. Front Oncol. 2021. PMID: 34178661 Free PMC article. Retracted. Review.
34 results